Search Results - "Lopez, Adriana T"
-
1
Treatment Outcomes of Immune-Related Cutaneous Adverse Events
Published in Journal of clinical oncology (20-10-2019)“…The aim of the current study was to report the efficacy of topical and systemic treatments for immune-related cutaneous adverse events (ircAEs) attributed to…”
Get full text
Journal Article -
2
A Case of Nivolumab‐Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein‐1/Programmed Death Ligand‐1 Inhibitors and Recommendations for Diagnosis and Management
Published in The oncologist (Dayton, Ohio) (01-10-2018)“…Immunotherapy has emerged as a highly effective treatment for numerous cancers. Use of checkpoint inhibitors against various molecules including programmed…”
Get full text
Journal Article -
3
Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma
Published in American journal of clinical dermatology (01-12-2018)“…Cutaneous T-cell lymphomas (CTCLs) are a heterogeneous group of lymphomas that are characterized by primary skin involvement. Mycosis fungoides (MF) and Sézary…”
Get full text
Journal Article -
4
A review of bullous pemphigoid associated with PD‐1 and PD‐L1 inhibitors
Published in International journal of dermatology (01-06-2018)“…Background Dermatologic toxicity represents a substantial portion of all immune‐related adverse events (irAEs) associated with PD‐1/PD‐L1 inhibitors. Bullous…”
Get full text
Journal Article -
5
-
6
UV biomarker genes for classification and risk stratification of cutaneous actinic keratoses and squamous cell carcinoma subtypes
Published in The FASEB journal (01-09-2020)“…Currently, there is no sensitive molecular test for identifying transformation‐prone actinic keratoses (AKs) and aggressive squamous cell carcinoma (SCC)…”
Get full text
Journal Article -
7
Fall risk assessment and injury prevention in the Mohs surgery clinic: a review of the literature and recommendations for improving patient safety
Published in Dermatology online journal (2019)“…Patient falls remain a major cause of adverse events in the medical setting. Many patients receiving Mohs micrographic surgery are at high risk, both for…”
Get full text
Journal Article -
8
The Role of Oncolytic Viruses in the Treatment of Melanoma
Published in Current oncology reports (01-10-2018)“…Purpose of Review Oncolytic virotherapy is a new approach to the treatment of cancer and its success in the treatment of melanoma represents a breakthrough in…”
Get full text
Journal Article -
9
Nevus anemicus: An island of sparing in the setting of drug-induced hypersensitivity
Published in JAAD Case Reports (01-07-2018)Get full text
Journal Article -
10
Correction to: The Role of Oncolytic Viruses in the Treatment of Melanoma
Published in Current oncology reports (01-12-2018)“…A correction was made to a sentence in the original article to provide additional clarification in the “Other Oncolytic Viruses” section…”
Get full text
Journal Article -
11
-
12
Secondary prevention strategies for nonmelanoma skin cancer
Published in Dermatology Times (01-06-2018)“…SECONDARY PREVENTION Ultraviolet (UV) radiation is the most preventable cause of skin cancer.7 Primary prevention efforts have focused on increasing awareness…”
Get full text
Trade Publication Article -
13
Nevus anemicus: An island of sparing in the setting of drug-induced hypersensitivity
Published in JAAD case reports (01-07-2018)Get full text
Report